The next step of neurogenesis in the context of Alzheimer's disease

Mol Biol Rep. 2021 Jul;48(7):5647-5660. doi: 10.1007/s11033-021-06520-9. Epub 2021 Jul 7.

Abstract

Among different pathological mechanisms, neuronal loss and neurogenesis impairment in the hippocampus play important roles in cognitive decline in Alzheimer's disease (AD). AD is a progressive and complex neurodegenerative diseases, which is very debilitating. The purpose of this paper is to review recent research into neurogenesis and AD and discuss how pharmacological drugs and herbal active components have impacts on neurogenesis and consequently improve cognitive functions. To date, despite huge research, no effective treatment has been approved for AD. Therefore, an avenue for future research and drug discovery is stimulating adult hippocampal neurogenesis (AHN). Evidence suggests that neurogenesis is regulated by the pharmacological treatment that may be recommended as a part of prophylaxis and therapeutic options for AD. However, the underlying mechanisms of regulating neurogenesis in AD are not well understood. To this point, we highlight to achieve an efficient treatment in AD by manipulating neurogenesis, it's necessary to target all steps of neurogenesis.

Keywords: Alzheimer’s Disease; Cognitive Function; Herbal Medicine; Neurogenesis; Pharmacology.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / etiology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Alzheimer Disease / therapy*
  • Animals
  • Biomarkers
  • Combined Modality Therapy
  • Disease Management
  • Disease Susceptibility
  • Drug Development
  • Drug Discovery
  • Humans
  • Molecular Targeted Therapy
  • Neurogenesis* / drug effects
  • Neurogenesis* / genetics
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology

Substances

  • Biomarkers